| 3987- | betaCar, | Lyco, | Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection |
| - | Trial, | AD, | NA |
| 3988- | betaCar, | Lut, | Zeax, | Effects of egg consumption on carotenoid absorption from co-consumed, raw vegetables |
| - | Trial, | AD, | NA |
| 3989- | betaCar, | Dietary factors that affect the bioavailability of carotenoids |
| 4083- | betaCar, | Significance of vitamin A to brain function, behavior and learning |
| - | Review, | AD, | NA |
| 4082- | betaCar, | Marginal vitamin A deficiency facilitates Alzheimer's pathogenesis |
| - | Study, | AD, | NA |
| 4081- | betaCar, | Vitamin A supplementation and risk of skeletal fracture |
| - | Study, | NA, | NA |
| 4080- | betaCar, | Vitamin A and Alzheimer's disease |
| - | Review, | AD, | NA |
| 4078- | betaCar, | VitC, | VitB6, | Impact of Diet on Learning, Memory and Cognition |
| - | Review, | AD, | NA |
| 5557- | betaCar, | The Effect of Beta-Carotene on Cognitive Function: A Systematic Review |
| - | Review, | Nor, | NA |
| 5565- | betaCar, | β-Carotene, a Potent Amyloid Aggregation Inhibitor, Promotes Disordered Aβ Fibrillar Structure |
| - | Study, | AD, | NA |
| 5558- | betaCar, | Re-remembering the influence of randomized β-carotene on cognitive decline |
| - | Analysis, | AD, | NA |
| 5559- | betaCar, | Low blood carotenoid status in dementia and mild cognitive impairment: A systematic review and meta-analysis |
| - | Review, | AD, | NA |
| 5560- | betaCar, | β-Carotene: A Natural Compound Improves Cognitive Impairment and Oxidative Stress in a Mouse Model of Streptozotocin-Induced Alzheimer's Disease |
| - | in-vivo, | AD, | NA |
| 5561- | betaCar, | Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease |
| - | Review, | AD, | NA |
| - | Study, | AD, | NA |
| 5563- | betaCar, | Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease |
| - | Review, | AD, | NA |
| 5564- | betaCar, | β-Carotene: A Natural Compound Improves Cognitive Impairment and Oxidative Stress in a Mouse Model of Streptozotocin-Induced Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 5518- | BEV, | Chemo, | Bevacizumab |
| - | Review, | Var, | NA | - | Review, | AMD, | NA |
| 5517- | BEV, | Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors |
| - | Review, | Var, | NA |
| 5516- | BEV, | immuno, | Chemo, | Targeting vascular normalization: a promising strategy to improve immune–vascular crosstalk in cancer immunotherapy |
| - | Review, | Var, | NA |
| 5515- | BEV, | Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro. |
| - | Review, | Var, | NA |
| 5594- | BEV, | immuno, | Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC |
| - | Human, | NSCLC, | NA |
| 5595- | BEV, | Chemo, | Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer |
| - | Human, | CRC, | NA |
| 5596- | BEV, | Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study |
| - | Study, | GBM, | NA |
| 5722- | BF, | Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells |
| - | in-vitro, | PC, | PANC1 |
| 5729- | BF, | Bufalin: a potential drug for regulating EGFR-TKIs resistance in lung cancer via the EGFR-PI3K/Akt-mTOR signaling |
| - | in-vitro, | Lung, | NA |
| 5723- | BF, | Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A |
| - | Study, | NA, | NA |
| 5724- | BF, | A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice |
| - | vitro+vivo, | Lung, | A549 |
| 5725- | BF, | TMZ, | Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide |
| - | in-vitro, | GBM, | NA |
| 5726- | BF, | Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species-mediated apoptosis by targeting the electron transport chain |
| - | Review, | neuroblastoma, | SK-N-BE |
| 5727- | BF, | Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221 |
| - | in-vitro, | OS, | U2OS |
| 5728- | BF, | Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action |
| - | in-vitro, | Lung, | A549 |
| 5721- | BF, | Bufalin Suppresses Triple-Negative Breast Cancer Stem Cell Growth by Inhibiting the Wnt/β-Catenin Signaling Pathway |
| - | in-vitro, | BC, | NA |
| 5720- | BF, | Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway |
| - | in-vitro, | NSCLC, | NA |
| 5730- | BF, | Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1 |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Lung, | A549 |
| 5719- | BF, | Bufalin inhibits the proliferation of lung cancer cells by suppressing Hippo-YAP pathway |
| - | in-vitro, | Lung, | NA |
| 5718- | BF, | Bufalin inhibits CYP3A4 activity in vitro and in vivo |
| - | in-vivo, | Nor, | NA |
| - | Trial, | Var, | NA |
| 5716- | BF, | Pilot Study of Huachansu in Patients with Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, or Pancreatic Cancer |
| - | Trial, | NSCLC, | NA | - | Trial, | PC, | NA | - | Trial, | HCC, | NA |
| 5715- | BF, | Bufalin for an innovative therapeutic approach against cancer |
| - | Review, | Var, | NA |
| 5597- | Bical, | Bicalutamide: clinical pharmacokinetics and metabolism |
| - | Review, | Pca, | NA |
| 2502- | Bical, | Complete Response of Metastatic Androgen Receptor–Positive Breast Cancer to Bicalutamide: Case Report and Review of the Literature |
| - | Case Report, | BC, | NA |
| 1250- | Bif, | Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12 |
| - | in-vitro, | SCC, | NA |
| 5621- | Bif, | immuno, | Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy |
| 5622- | Bif, | Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice |
| - | in-vivo, | Var, | NA |
| 5623- | Bif, | Bifidobacterium breve predicts the efficacy of anti-PD-1 immunotherapy combined with chemotherapy in Chinese NSCLC patients |
| - | Study, | NSCLC, | NA |
| 5625- | Bif, | immuno, | The gut microbiome and cancer response to immune checkpoint inhibitors |
| - | Review, | Var, | NA |
| 5626- | Bif, | Bifidobacterium in anticancer immunochemotherapy: friend or foe? |
| - | Review, | Var, | NA |
| 5627- | Bif, | Efficacy and Safety of Probiotics as Adjunctive Therapy in Cancer Treatment: A Comprehensive Systematic Review and Meta-Analysis |
| - | Review, | Var, | NA |
| 5628- | Bif, | immuno, | Bifidobacterium modulation of tumor immunotherapy and its mechanism |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid